GBT
CVKD icon

Grove Bank & Trust’s Cadrenal Therapeutics CVKD Stock Holding History

Grove Bank & Trust’s Portfolio CVKD Stock Details CVKD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.34K Buy
+1,000
New +$4.75K ﹤0.01% 767

Other funds holding CVKD

CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Grove Bank & Trust's CVKD Position: Q2 2026 in Review

Grove Bank & Trust opened a new position in Cadrenal Therapeutics (CVKD) in Q2 2026: 1,000 shares worth $3.34K. The stake represents ﹤0.01% of the portfolio and ranks #767 among its holdings.

3 funds tracked by Wall St. Rank hold CVKD as of Q2 2026.

  • Grove Bank & Trust held 1,000 shares of Cadrenal Therapeutics worth $3.34K as of Q2 2026.
  • Cadrenal Therapeutics was a new Grove Bank & Trust position in Q2 2026.
  • Cadrenal Therapeutics made up ﹤0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #767 holding.
  • 3 funds tracked by Wall St. Rank held Cadrenal Therapeutics as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.